VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Atlas Copco AB (publ) vs Gilead Sciences, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Atlas Copco AB (publ)
ATCO-A · Nasdaq Stockholm
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Atlas Copco AB (publ)'s moat claims, evidence, and risks.
View ATCO-A analysisGilead Sciences, Inc.
GILD · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Gilead Sciences, Inc.'s moat claims, evidence, and risks.
View GILD analysisComparison highlights
- Moat score gap: Gilead Sciences, Inc. leads (74 / 100 vs 63 / 100 for Atlas Copco AB (publ)).
- Segment focus: Atlas Copco AB (publ) has 4 segments (43.8% in Compressor Technique); Gilead Sciences, Inc. has 5 segments (68.5% in HIV).
- Moat breadth: Atlas Copco AB (publ) has 6 moat types across 2 domains; Gilead Sciences, Inc. has 8 across 3.
Primary market context
Atlas Copco AB (publ)
Compressor Technique
Industrial compressors, air/gas systems (including air treatment) and related aftermarket service
Global
Industrial and process customers; distributors; service-contract customers
Equipment OEM + aftermarket service provider
43.8%
Gilead Sciences, Inc.
HIV
HIV treatment and prevention medicines (antiretroviral therapy and PrEP)
Global (U.S. and Europe are major markets)
Patients/prescribers; reimbursed by public and private payers; distributed via wholesalers and specialty pharmacies
Drug developer and marketing authorization holder
68.5%
Side-by-side metrics
Moat coverage
Shared moat types
Atlas Copco AB (publ) strengths
Gilead Sciences, Inc. strengths
Segment mix
Atlas Copco AB (publ) segments
Full profile >Compressor Technique
Oligopoly
Vacuum Technique
Oligopoly
Industrial Technique
Oligopoly
Power Technique
Competitive
Gilead Sciences, Inc. segments
Full profile >HIV
Oligopoly
Oncology (Cell Therapy + Trodelvy)
Oligopoly
Liver Disease
Oligopoly
Veklury (Remdesivir)
Competitive
Other Products
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.